These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11320187)
41. Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function. de Andrade PB; Rubi B; Frigerio F; van den Ouweland JM; Maassen JA; Maechler P Diabetologia; 2006 Aug; 49(8):1816-26. PubMed ID: 16736129 [TBL] [Abstract][Full Text] [Related]
42. Clinical features associated with the A-->G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Silvestri G; Ciafaloni E; Santorelli FM; Shanske S; Servidei S; Graf WD; Sumi M; DiMauro S Neurology; 1993 Jun; 43(6):1200-6. PubMed ID: 8170567 [TBL] [Abstract][Full Text] [Related]
43. Macular dystrophy associated with the A3243G mitochondrial DNA mutation. Distinct retinal and associated features, disease variability, and characterization of asymptomatic family members. Michaelides M; Jenkins SA; Bamiou DE; Sweeney MG; Davis MB; Luxon L; Bird AC; Rath PP Arch Ophthalmol; 2008 Mar; 126(3):320-8. PubMed ID: 18332310 [TBL] [Abstract][Full Text] [Related]
44. Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Jeppesen TD; Schwartz M; Olsen DB; Wibrand F; Krag T; Dunø M; Hauerslev S; Vissing J Brain; 2006 Dec; 129(Pt 12):3402-12. PubMed ID: 16815877 [TBL] [Abstract][Full Text] [Related]
45. The genetics and pathology of oxidative phosphorylation. Smeitink J; van den Heuvel L; DiMauro S Nat Rev Genet; 2001 May; 2(5):342-52. PubMed ID: 11331900 [TBL] [Abstract][Full Text] [Related]
46. Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy. Lodi R; Taylor DJ; Tabrizi SJ; Hilton-Jones D; Squier MV; Seller A; Styles P; Schapira AH Brain; 1998 Nov; 121 ( Pt 11)():2119-26. PubMed ID: 9827771 [TBL] [Abstract][Full Text] [Related]
47. Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy. Andreu AL; Bruno C; Shanske S; Shtilbans A; Hirano M; Krishna S; Hayward L; Systrom DS; Brown RH; DiMauro S Neurology; 1998 Nov; 51(5):1444-7. PubMed ID: 9818877 [TBL] [Abstract][Full Text] [Related]
48. [Mitochondrial diseases--causes and diagnosis]. Bartnik E; Mroczek K Med Wieku Rozwoj; 1999; 3(1):15-21. PubMed ID: 10910634 [TBL] [Abstract][Full Text] [Related]
49. Phenotypic heterogeneity in a Chinese family with mitochondrial disease and A3243G mutation of mitochondrial DNA. Thajeb P; Lee HC; Pang CY; Jeng CM; Huang SF; Wei YH Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):71-6. PubMed ID: 10645055 [TBL] [Abstract][Full Text] [Related]
50. Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders. Sternberg D; Chatzoglou E; Laforêt P; Fayet G; Jardel C; Blondy P; Fardeau M; Amselem S; Eymard B; Lombès A Brain; 2001 May; 124(Pt 5):984-94. PubMed ID: 11335700 [TBL] [Abstract][Full Text] [Related]
51. A boy with muscle weakness, hypercarbia, and the mitochondrial DNA A3243G mutation. Saneto RP; Bouldin A J Child Neurol; 2006 Jan; 21(1):77-9. PubMed ID: 16551459 [TBL] [Abstract][Full Text] [Related]
52. Clinical characteristics and muscle pathology in myopathic mitochondrial DNA depletion. Nevo Y; Soffer D; Kutai M; Zelnik N; Saada A; Jossiphov J; Messer G; Shaag A; Shahar E; Harel S; Elpeleg O J Child Neurol; 2002 Jul; 17(7):499-504. PubMed ID: 12269728 [TBL] [Abstract][Full Text] [Related]
53. Age-related mitochondrial DNA point mutations in patients with mitochondrial myopathy. da Costa CK; Kiyomoto BH; Schmidt B; Oliveira AS; Gabbai AA; Tengan CH J Neurol Sci; 2007 Dec; 263(1-2):139-44. PubMed ID: 17698085 [TBL] [Abstract][Full Text] [Related]
54. [Cerebral aging and mitochondria]. Ortí-Pareja M; Jiménez-Jiménez FJ; Molina-Arjona JA Rev Neurol; 1998 Apr; 26 Suppl 1():S107-11. PubMed ID: 9810598 [TBL] [Abstract][Full Text] [Related]
55. [Mitochondriopathies]. Ricoy-Campo JR; Cabello A Rev Neurol; 2003 Oct 16-31; 37(8):775-9. PubMed ID: 14593640 [TBL] [Abstract][Full Text] [Related]
56. Renal amino acid transport in adults with oxidative phosphorylation diseases. Shoffner JM; Voljavec AS; Dixon J; Kaufman A; Wallace DC; Mitch WE Kidney Int; 1995 Apr; 47(4):1101-7. PubMed ID: 7783407 [TBL] [Abstract][Full Text] [Related]
57. Increased risk for cardiorespiratory failure associated with the A3302G mutation in the mitochondrial DNA encoded tRNALeu(UUR) gene. van den Bosch BJ; de Coo IF; Hendrickx AT; Busch HF; de Jong G; Scholte HR; Smeets HJ Neuromuscul Disord; 2004 Oct; 14(10):683-8. PubMed ID: 15351426 [TBL] [Abstract][Full Text] [Related]
58. In vivo assessment of human skeletal muscle mitochondria respiration in health and disease. Barbiroli B; Iotti S; Lodi R Mol Cell Biochem; 1997 Sep; 174(1-2):11-5. PubMed ID: 9309659 [TBL] [Abstract][Full Text] [Related]
59. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Kornblum C; Schröder R; Müller K; Vorgerd M; Eggers J; Bogdanow M; Papassotiropoulos A; Fabian K; Klockgether T; Zange J Eur J Neurol; 2005 Apr; 12(4):300-9. PubMed ID: 15804248 [TBL] [Abstract][Full Text] [Related]
60. Distinctive distribution of brain volume reductions in MELAS and mitochondrial DNA A3243G mutation carriers: A voxel-based morphometric study. Tsujikawa K; Senda J; Yasui K; Hasegawa Y; Hoshiyama M; Katsuno M; Sobue G Mitochondrion; 2016 Sep; 30():229-35. PubMed ID: 27558483 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]